原发性前列腺癌患者68Ga-PSMA-11动力学建模及简化定量方法的验证
15例组织学证实原发性前列腺癌患者行60分钟动态68Ga-PSMA-11 PET盆腔扫描并同步采集MR图像,共识别18个阳性病灶。68Ga-PSMA-11动力学由不可逆双组织室模型最佳描述,MR引导的图像衍生血液法与动脉采血法所得Ki一致性极佳(组内相关系数=0.99),SUV与Ki显著相关且以30-45分钟时间窗相关性最强(rho 0.95,p<0.001)。
要点
- 68Ga-PSMA-11在体内稳定,动力学由不可逆双组织室模型最佳描述。
- MR引导图像衍生血液法与动脉采血法Ki一致性极佳(组内相关系数=0.99)。
- SUV与Ki显著相关,30-45分钟时间窗相关性最强(rho 0.95,p<0.001)。
核心结论
- 68Ga-PSMA-11动力学可由不可逆双组织室模型描述。
- MR引导的图像衍生血液法为动力学建模研究提供了一种非侵入性替代采血的方法。
- SUV与Ki强相关,可用于常规临床环境中量化68Ga-PSMA-11摄取。
研究设计与样本
- 15例组织学证实原发性前列腺癌患者接受60分钟动态68Ga-PSMA-11 PET盆腔扫描,同步采集轴位T1 Dixon、T2及扩散加权MR图像。
- 从病灶、正常前列腺和肌肉的感兴趣体积中提取时间-活动曲线并计算平均SUV。
- 通过自动动脉采血和手动血样采集进行血浆-全血比校正及代谢物分析。
- 基于赤池信息准则选择动力学模型,比较病灶与正常组织的速率常数。
- 评估MR引导图像衍生血液法与动脉采血法所得Ki的一致性,以及SUV与Ki的相关性。
主要发现
- PET与MR共识别18个阳性病灶。
- 分析显示68Ga-PSMA-11在体内稳定。
- 基于赤池信息准则,68Ga-PSMA-11动力学由不可逆双组织室模型最佳描述。
- 病灶的速率常数K1、k3及净流入速率常数Ki均显著高于正常组织(p<0.05)。
- MR引导图像衍生血液法所得Ki与动脉采血法所得Ki一致性极佳(组内相关系数=0.99)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The positron emission tomography (PET) ligand 68Ga-Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11) targets the prostate-specific membrane antigen (PSMA), upregulated in prostate cancer cells. Although 68Ga-PSMA-11 PET is widely used in research and clinical practice, full kinetic modeling has not yet been reported nor have simplified methods for quantification been validated. The aims of our study were to quantify 68Ga-PSMA-11 uptake in primary prostate cancer patients using compartmental modeling with arterial blood sampling and to validate the use of standardized uptake values (SUV) and image-derived blood for quantification. RESULTS: Fifteen patients with histologically proven primary prostate cancer underwent a 60-min dynamic 68Ga-PSMA-11 PET scan of the pelvis with axial T1 Dixon, T2, and diffusion-weighted magnetic resonance (MR) images acquired simultaneously. Time-activity curves were derived from volumes of interest in lesions, normal prostate, and muscle, and mean SUV calculated. In total, 18 positive lesions were identified on both PET and MR. Arterial blood activity was measured by automatic arterial blood sampling and manual blood samples were collected for plasma-to-blood ratio correction and for metabolite analysis. The analysis showed that 68Ga-PSMA-11 was stable in vivo. Based on the Akaike information criterion, 68Ga-PSMA-11 kinetics were best described by an irreversible two-tissue compartment model. The rate constants K1 and k3 and the net influx rate constants Ki were all significantly higher in lesions compared to normal tissue (p < 0.05). Ki derived using image-derived blood from an MR-guided method showed excellent agreement with Ki derived using arterial blood sampling (intraclass correlation coefficient = 0.99). SUV correlated significantly with Ki with the strongest correlation of scan time-window 30-45 min (rho 0.95, p < 0.001). Both Ki and SUV correlated significantly with serum prostate specific antigen (PSA) level and PSA density. CONCLUSIONS: 68Ga-PSMA-11 kinetics can be described by an irreversible two-tissue compartment model. An MR-guided method for image-derived blood provides a non-invasive alternative to blood sampling for kinetic modeling studies. SUV showed strong correlation with Ki and can be used in routine clinical settings to quantify 68Ga-PSMA-11 uptake.
引用
- Ringheim A, Campos Neto GC, Anazodo U, et al. Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients. EJNMMI Res. 2020. PMID: 32140850. doi:10.1186/s13550-020-0594-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。